Caliber Imaging & Diagnostics, Inc. (LCDX)

Market Cap	5.15K +200.1%
Revenue (ttm)	3.14M -1.1%
Net Income	-6.25M
EPS	-0.75
Shares Out	8.58M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Average Volume	2,991
Open	0.0006
Previous Close	n/a
Day's Range	0.0006 - 0.0006
52-Week Range	0.0001 - 0.0006
Beta	0.17
RSI	62.80
Earnings Date	n/a

About LCDX

Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1991
• Employees: 28
• Stock Exchange: OTCMKTS
• Ticker Symbol: LCDX

Financial Performance

In 2013, LCDX's revenue was $3.34 million, an increase of 37.24% compared to the previous year's $2.43 million. Losses were -$5.48 million, -44.21% less than in 2012.